Market forecast of hypertrophic and keloid scars until 2027

The market for the treatment of hypertrophic and keloid scars is estimated at $ 4,498. 99 million in 2019, and is projected to reach $ 9,972. 69 million by 2027; CAGR growth is expected to be 10.6% from 2020 to 2027.

New York, February 23, 2021 (GLOBE NEWSWIRE) – announces the publication of the report “Hypertrophic and Keloid Scar Treatment Market by 2027 – Impact and Global Analysis of COVID-19 by Scar Type, Product Type and End User and Geography” –

The benefits of laser treatment and the increased incidence of injuries are expected to boost market growth over the forecast period. However, the unavailability of universal treatment due to high costs, side effects, and poor awareness is hampering market growth.

Injuries and their prolongation deep in the dermis are a major cause of hypertrophic scars and keloids. Injuries can be further classified as scratches, burns, cuts, bruises, sutures, surgical incisions and so on.

The prevalence rate of injuries that eventually turn into keloid or hypertrophic scars is 5–15%. In addition, skin conditions such as acne and dark pigmentation lead to the development of hypertrophic and keloid scars.

Cases of different types of injuries are often seen among all age groups. Acne, sports injuries and traffic accidents are more common among young people.

Acne is also a common problem among middle-aged people, regardless of their gender. Hormonal imbalance among people leads to acne, which can leave serious scars on the skin. It is estimated that acne affects about 10% of the total global population. For example, according to the American Academy of Dermatological Associations, acne is the most common skin disease in the United States, affecting about 50 million Americans annually. ~ 85% of people in the 12-24 age group have fewer acne problems. Lifestyle changes, habits and increasing stress greatly contribute to acne problems. Therefore, the trend of treating scars caused by acne is much higher in the world.
According to WHO data published in February 2020, injuries caused by traffic accidents are the leading cause of death among young people aged 5 to 29. ~ 1.35 million deaths are registered annually due to traffic accidents. However, the rate of serious injuries in traffic accidents is also growing. Therefore, an increasing number of accidents indirectly leads to a growing demand for hypertrophic and keloid scar treatments.
Based on the type of scars, the market for hypertrophic and keloid scars is divided into hypertrophic and keloid. The hypertrophic segment took a larger share of the market in 2019, as hypertrophic scars are more common.

Moreover, these scars do not grow beyond the boundaries of the original wound and eventually become smaller. In addition, the treatment of hypertrophic scars usually requires non-invasive procedures such as gels, creams and silicone foils during minor injuries and laser treatments.

Therefore, it is estimated that the segment will record a higher CAGR in the market over the forecast period.
As for the type of product, the market of hypertrophic and keloid scars is segmented into laser products, topical products, injections and other products. The injection segment had the largest market share in 2019 and is estimated to have recorded the largest CAGR in the market over the forecast period.
Based on the end user, the market for the treatment of hypertrophic and keloid scars is divided into hospitals, clinics and home care. The hospital segment held the largest market share in 2019 and is estimated to record the largest CAGR in the market over the forecast period.
The American Society of Plastic Surgeons, the Burns-India National Academy, the European Medicines Agency and Nippon Medical School are among the main secondary sources cited when preparing the market report for the treatment of hypertrophic and keloid scars.
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – right now, in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001